59
Participants
Start Date
September 30, 2015
Primary Completion Date
September 26, 2020
Study Completion Date
September 26, 2020
vargatef®
Patients will be treated to oral nintedanib (vargatef®) 400 mg/d on days 2 to 21 of a 3-week cycle
Docetaxel
Patients will be treated to IV docetaxel 75 mg/m² on day 1 of evry 3-week cycle
Centre Hospitalier F. Quesnay, Mantes-la-Jolie
CHU de Limoges, Limoges
CH de Beauvais, Beauvais
CHU Brest, Brest
Service de Pneumologie, Créteil
Service de Pneumologie, Gap
CH de Bretagne Sud, Lorient
AP-HM, Marseille
Institut Paoli-Calmettes, Marseille
Instiut de Cancérologie, Saint-Etienne
Service de Pneumologie, Villefranche
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
University Hospital, Limoges
OTHER